Physiologically Based Pharmacokinetic (PBPK) Modeling to Predict PET Image Quality of Three Generations EGFR TKI in Advanced-Stage NSCLC Patients.

MLA

Bartelink, I. H., et al. “Physiologically Based Pharmacokinetic (PBPK) Modeling to Predict PET Image Quality of Three Generations EGFR TKI in Advanced-Stage NSCLC Patients.” Pharmaceuticals (Basel, Switzerland), vol. 15, no. 7, June 2022. EBSCOhost, https://doi.org/10.3390/ph15070796.

APA

Bartelink, I. H., van de Stadt, E. A., Leeuwerik, A. F., Thijssen, V. L. J. L., Hupsel, J. R. I., van den Nieuwendijk, J. F., Bahce, I., Yaqub, M., & Hendrikse, N. H. (2022). Physiologically Based Pharmacokinetic (PBPK) Modeling to Predict PET Image Quality of Three Generations EGFR TKI in Advanced-Stage NSCLC Patients. Pharmaceuticals (Basel, Switzerland), 15(7). https://doi.org/10.3390/ph15070796

Chicago

Bartelink, I H, E A van de Stadt, A F Leeuwerik, V L J L Thijssen, J R I Hupsel, J F van den Nieuwendijk, I Bahce, M Yaqub, and N H Hendrikse. 2022. “Physiologically Based Pharmacokinetic (PBPK) Modeling to Predict PET Image Quality of Three Generations EGFR TKI in Advanced-Stage NSCLC Patients.” Pharmaceuticals (Basel, Switzerland) 15 (7). doi:10.3390/ph15070796.